Jeffrey Raizer, MD
Northwestern University
8
7
4
N/A
0
4
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+5 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (8)
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Steven Chmura, MD
University of Chicago
Shared therapeutic areas:
Worked with same sponsors:
Antonio Omuro, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Jay-Jiguang Zhu, MD
Tufts Medical Center
Shared therapeutic areas:
Worked with same sponsors:
David Schiff, MD
University of Virginia
Shared therapeutic areas:
Worked with same sponsors:
Jan Drappatz, MD
Dana-Farber Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Richard Wahl, MD
Johns Hopkins University
Shared therapeutic areas:
Worked with same sponsors:
Thomas Gribbin, MD
St. Mary's Health Care
Shared therapeutic areas:
Worked with same sponsors:
Sean Grimm, MD
Northwestern University
Shared therapeutic areas:
Worked with same sponsors:
Michael Edgeworth, MD
Vanderbilt University
Shared therapeutic areas:
Worked with same sponsors:
Heather Jacene, MD
Johns Hopkins University
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (8)
Showing 8 of 8 trials
Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma
Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma
A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
Presurgery Bortezomib for Recurrent Malignant Gliomas Followed by Postop Bortezomib & Temozolomide
Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer
All 8 trials loaded